These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 3332755)

  • 1. The impact of genetic engineering on the commercial production of antibiotics by Streptomyces and related bacteria.
    Hutchinson CR
    Appl Biochem Biotechnol; 1987; 16():169-90. PubMed ID: 3332755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The improving prospects for yield increase by genetic engineering in antibiotic-producing Streptomycetes.
    Chater KF
    Biotechnology (N Y); 1990 Feb; 8(2):115-21. PubMed ID: 1366556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic engineering of Streptomyces to create hybrid antibiotics.
    Hopwood DA
    Curr Opin Biotechnol; 1993 Oct; 4(5):531-7. PubMed ID: 7764202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics and biochemistry on tylosin production: a model for genetic engineering in antibiotic-producing Streptomyces.
    Baltz RH
    Basic Life Sci; 1982; 19():431-44. PubMed ID: 6950720
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic manipulation of antibiotic-producing Streptomyces.
    Baltz RH
    Trends Microbiol; 1998 Feb; 6(2):76-83. PubMed ID: 9507643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature's combinatorial biosynthesis and recently engineered production of nucleoside antibiotics in Streptomyces.
    Chen S; Kinney WA; Van Lanen S
    World J Microbiol Biotechnol; 2017 Apr; 33(4):66. PubMed ID: 28260195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved antibiotic production and silent gene activation in Streptomyces diastatochromogenes by ribosome engineering.
    Shentu X; Liu N; Tang G; Tanaka Y; Ochi K; Xu J; Yu X
    J Antibiot (Tokyo); 2016 May; 69(5):406-10. PubMed ID: 26648118
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancing macrolide production in Streptomyces by coexpressing three heterologous genes.
    Wang T; Bai L; Zhu D; Lei X; Liu G; Deng Z; You D
    Enzyme Microb Technol; 2012 Jan; 50(1):5-9. PubMed ID: 22133433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug development through the genetic engineering of antibiotic-producing microorganisms.
    Hutchinson CR; Borell CW; Donovan MJ; Kato F; Motamedi H; Nakayama H; Otten SL; Rubin RL; Streicher SL; Stutzman-Engwall KJ
    Ann N Y Acad Sci; 1991 Dec; 646():78-93. PubMed ID: 1809208
    [No Abstract]   [Full Text] [Related]  

  • 10. [The All-Union methodological seminar on "Cellular engineering of antibiotic producers"].
    Sazykin IuO
    Antibiot Khimioter; 1988 Mar; 33(3):163-4. PubMed ID: 3163913
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production of new antibiotics. Problems and prospects].
    Dudnik IuV
    Antibiot Khimioter; 1989 Nov; 34(11):807-10. PubMed ID: 2633693
    [No Abstract]   [Full Text] [Related]  

  • 12. Environmental DNA fragment conferring early and increased sporulation and antibiotic production in Streptomyces species.
    Martinez A; Kolvek SJ; Hopke J; Yip CL; Osburne MS
    Appl Environ Microbiol; 2005 Mar; 71(3):1638-41. PubMed ID: 15746369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New route to antibiotic creation.
    Demain AL
    Nature; 1985 Apr 18-24; 314(6012):577-8. PubMed ID: 3857463
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioactive products from Streptomyces.
    Bĕhal V
    Adv Appl Microbiol; 2000; 47():113-56. PubMed ID: 12876796
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of 'hybrid' antibiotics by genetic engineering.
    Hopwood DA; Malpartida F; Kieser HM; Ikeda H; Duncan J; Fujii I; Rudd BA; Floss HG; Omura S
    Nature; 1985 Apr 18-24; 314(6012):642-4. PubMed ID: 3857464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery and development through the genetic engineering of antibiotic-producing microorganisms.
    Hutchinson CR; Borell CW; Otten SL; Stutzman-Engwall KJ; Wang YG
    J Med Chem; 1989 May; 32(5):929-37. PubMed ID: 2651668
    [No Abstract]   [Full Text] [Related]  

  • 17. Construction of kanamycin B overproducing strain by genetic engineering of Streptomyces tenebrarius.
    Ni X; Li D; Yang L; Huang T; Li H; Xia H
    Appl Microbiol Biotechnol; 2011 Feb; 89(3):723-31. PubMed ID: 20936279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of spectinomycin: heterologous production of spectinomycin and spectinamine in an aminoglycoside-deficient host, Streptomyces venezuelae YJ003.
    Thapa LP; Oh TJ; Liou K; Sohng JK
    J Appl Microbiol; 2008 Jul; 105(1):300-8. PubMed ID: 18355231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics.
    Miao V; Coëffet-Le Gal MF; Nguyen K; Brian P; Penn J; Whiting A; Steele J; Kau D; Martin S; Ford R; Gibson T; Bouchard M; Wrigley SK; Baltz RH
    Chem Biol; 2006 Mar; 13(3):269-76. PubMed ID: 16638532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of gougerotin and nikkomycin production by engineering their biosynthetic gene clusters.
    Du D; Zhu Y; Wei J; Tian Y; Niu G; Tan H
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6383-96. PubMed ID: 23515837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.